Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 83

Sort by

Sort Order Select

Journal Articles

Availability of blood products and transfusion practices in sub-saharan Africa for the management of patients with sickle cell disease: A survey in 16 countries.

Geoffrey Cheminet, Saliou Diop, Françoise Bernaudin, Indou Deme-Ly, Binta Coulibaly, Anne Corbasson, Ibrahima Diagne, Charlotte Eposse Ekoube, Frederic Galacteros, Olivier Hermine, Eléonore Kafando, Mariane de Montalembert, Constant Vodouhé, Ahoefa Vovor, Brigitte Ranque, Leon Tshilolo, France Pirenne, Dapa Diallo, Jean-Benoit Arlet

Blood (2025) 146 (Supplement 1): 2966.

https://doi.org/10.1182/blood-2025-2966

Published: 2025

Journal Articles

Subtotal versus total splenectomy in children with sickle cell disease: Clinical outcomes and splenic function assessed by pocked red blood cell count

Alma Al Sibaaie, Abdoulaye Sissoko, Carmen Capito, Christophe Chardot, Mariane de Montalembert, Valentine Brousse, Melissa Taylor, Joséphine Brice, Martina Bevacqua, Lucie Dumas, Astan Cissé, Pierre Buffet, Slimane Allali

Blood (2025) 146 (Supplement 1): 2953.

https://doi.org/10.1182/blood-2025-2953

Published: 2025

Journal Articles

Sickle cell disease in europe: A cross-border real-world data analysis from the radeep registry

Blood (2025) 146 (Supplement 1): 179.

https://doi.org/10.1182/blood-2025-179

Published: 2025

Journal Articles

Long-term follow-up demonstrates durable clinical benefits of exagamglogene autotemcel for sickle cell disease with recurrent vaso-occlusive crises: Final results of climb SCD-121

Blood (2025) 146 (Supplement 1): 2537.

https://doi.org/10.1182/blood-2025-2537

Published: 2025

Journal Articles

Data validation and quality framework for building a european multimodal real-world dataset for clinical outcome research in sickle cell disease

Blood (2025) 146 (Supplement 1): 4443.

https://doi.org/10.1182/blood-2025-4443

Published: 2025

Journal Articles

First results of exagamglogene autotemcel in pediatric patients aged 5-11 years with transfusion-dependent β-thalassemia or sickle cell disease with recurrent severe vaso-occlusive crises

Blood (2025) 146 (Supplement 1): 379.

https://doi.org/10.1182/blood-2025-379

Published: 2025

Journal Articles

Association between inflammatory and hemolysis markers in children with sickle cell disease

Capucine Collet, Alma Al Sibaaie, Rachel Rignault-Bricard, Mariane de Montalembert, Joséphine Brice, Melissa Taylor, Martina Bevacqua, Olivier Hermine, Thiago Trovati Maciel, Slimane Allali

Blood (2025) 146 (Supplement 1): 6492.

https://doi.org/10.1182/blood-2025-6492

Published: 2025

Journal Articles

Patient-driven insights in sickle cell disease: Results from a global survey informing public health strategies

Mariangela Pellegrini, Baba Inusa, Raffaella Colombatti, Issom David-Zacharie, Mariane de Montalembert, Piel Fréderic B., Béatrice Gulbis, Smith Lan-Lan, Maria Del Mar Mañú Pereira

Blood (2025) 146 (Supplement 1): 4441.

https://doi.org/10.1182/blood-2025-4441

Published: 2025

Journal Articles

Implementing patient-centered PROMs in sickle cell disease care: A european consensus approach

Anna Collado Gimbert, Betzabel Cajiao Garcia, Raffaella Colombatti, Mariane de Montalembert, Elisabetta Mezzalira, Eduard Van Beers, Maria Del Mar Mañú Pereira

Blood (2025) 146 (Supplement 1): 2666.

https://doi.org/10.1182/blood-2025-2666

Published: 2025

Journal Articles

Sickle cell disease trials redefined: Toward unified clinical endpoints through international consensus

Mohamed Yassin, Nirmish Shah, Andrew Campbell, Salam Al-Kindi, Wally Smith, Charles Jonassaint, Miguel Abboud, Raffaella Colombatti, Dipty Jain, Halima Bello-Manga, Mariane de Montalembert, Ana Silva-Pinto, Steven Okoli, Abdelaziz Fahem, Biree Andemariam

Blood (2025) 146 (Supplement 1): 1166.

https://doi.org/10.1182/blood-2025-1166

Published: 2025

Journal Articles

Autoimmune and Inflammatory Diseases in Children with Sickle Cell Disease: A French Multicenter Observational Study on Diagnostic and Therapeutic Issues

Blood (2024) 144 (Supplement 1): 1117.

https://doi.org/10.1182/blood-2024-208048

Published: 2024

Journal Articles

Oxygen Gradient Ektacytometry Is Associated with Markers of Hemolysis and Inflammation in a Large Sickle Cell Disease Cohort within the GenoMed4ALL Project

Blood (2024) 144 (Supplement 1): 290.

https://doi.org/10.1182/blood-2024-200639

Published: 2024

Journal Articles

Data Driven Research through the European RADeep Registry and the Use of Artificial Intelligence Towards Personalized Medicine in Sickle Cell Disease

Blood (2024) 144 (Supplement 1): 1138.

https://doi.org/10.1182/blood-2024-203331

Published: 2024

Journal Articles

Durable Clinical Benefits with Exagamglogene Autotemcel for Severe Sickle Cell Disease

Blood (2024) 144 (Supplement 1): 4954.

https://doi.org/10.1182/blood-2024-204001

Published: 2024

Journal Articles

Availability and Cost of Basic Drugs for Sickle Cell Disease in 13 African Countries

Gladys Kelly Keza, Dapa Aly Diallo, Ibrahima Diagne, Mariane de Montalembert, Anne Corbasson, Françoise Bernaudin, Brigitte Ranque, Binta Coulibaly, Galacteros Frederic, Saliou Diop, Constant Vodouhé, Olivier Hermine, Agnès Lainé, Eléonor Kafando, Ahoefa Vovor, Sébastien Jan, Leon Tshilolo, Robert Hue, Jean-Benoit Arlet

Blood (2023) 142 (Supplement 1): 1152.

https://doi.org/10.1182/blood-2023-188652

Published: 2023

Journal Articles

Safety Profile of Crizanlizumab 5.0 Mg/Kg in Sickle Cell Disease: Pooled Data from Clinical Trials

Abdullah Kutlar, Vikas Joshi, Andreas Brueckner, Julie Kanter, Darla K. Liles, Jeremie Lincy, Rahul Manjare, Yvonne Dei Adomakoh, Matthew M. Heeney, Mariane de Montalembert, Deborah Keefe, Kwaku Marfo, Kenneth I. Ataga

Blood (2023) 142 (Supplement 1): 1139.

https://doi.org/10.1182/blood-2023-188639

Published: 2023

Journal Articles

Puberty Onset and Preservation of Fertility in Male Patients with Sickle Cell Disease Treated with Hydroxyurea: Data from the European Sickle Cell Disease Cohort - Hydroxyurea Extension (ESCORT-HU Extension) Study

Mariane De Montalembert, Pablo Bartolucci, Gonzalo De Luna, Anoosha Habibi, Scylia Alexis-Fardini, Maryse Etienne-Julan, Gylna Loko, Giovanna Cannas, Jean-Benoit Arlet, Latifatou Boukari, Sylvain Le Jeune, Laure Joseph

Blood (2023) 142 (Supplement 1): 145.

https://doi.org/10.1182/blood-2023-178219

Published: 2023

Journal Articles

Sickle Cell Health Awareness, Perspectives, and Experiences (SHAPE) Survey: Findings on the Burden of Sickle Cell Disease and Impact on the Quality of Life of Patients and Caregivers in Gulf Cooperation Council Countries

Wasil Jastaniah, Regina Hartfield, John James, Biba Tinga, Elvie Ingoli, Mariane de Montalembert, Fernando F. Costa, Alan Randall Anderson, Joachim B. Kunz, Isaac Odame, Belinda Lartey, Baba P.D. Inusa

Blood (2023) 142 (Supplement 1): 2516.

https://doi.org/10.1182/blood-2023-177655

Published: 2023

Journal Articles

Exagamglogene Autotemcel for Severe Sickle Cell Disease

Blood (2023) 142 (Supplement 1): 1052.

https://doi.org/10.1182/blood-2023-190139

Published: 2023

Journal Articles

The Cs a and Cs b Red Cell Antigens of the Cost Blood Group Collection Correspond to the HNA-3a and HNA-3b Neutrophil Antigens: Unexpected Twins with Implications for Sickle Cell Anemia

Jonathan De Oliveira Rios, Alisa Soudry, Romain Duval, Alexandre Raneri, Thomas Poyot, Jérome Babinet, Mariane De Montalembert, Claudia Regina Bonini Domingos, Caroline Le Van Kim, Marc Romana, Thierry Peyrard, Slim Azouzi

Blood (2023) 142 (Supplement 1): 698.

https://doi.org/10.1182/blood-2023-178250

Published: 2023

Update search

NARROW

Publications

Format

Subjects

Article Type

Topics

Date

Availability

Availability of blood products and transfusion practices in sub-saharan Africa for the management of patients with sickle cell disease: A survey in 16 countries.

Subtotal versus total splenectomy in children with sickle cell disease: Clinical outcomes and splenic function assessed by pocked red blood cell count

Sickle cell disease in europe: A cross-border real-world data analysis from the radeep registry

Long-term follow-up demonstrates durable clinical benefits of exagamglogene autotemcel for sickle cell disease with recurrent vaso-occlusive crises: Final results of climb SCD-121

Data validation and quality framework for building a european multimodal real-world dataset for clinical outcome research in sickle cell disease

First results of exagamglogene autotemcel in pediatric patients aged 5-11 years with transfusion-dependent β-thalassemia or sickle cell disease with recurrent severe vaso-occlusive crises

Association between inflammatory and hemolysis markers in children with sickle cell disease

Patient-driven insights in sickle cell disease: Results from a global survey informing public health strategies

Implementing patient-centered PROMs in sickle cell disease care: A european consensus approach

Sickle cell disease trials redefined: Toward unified clinical endpoints through international consensus

Autoimmune and Inflammatory Diseases in Children with Sickle Cell Disease: A French Multicenter Observational Study on Diagnostic and Therapeutic Issues

Oxygen Gradient Ektacytometry Is Associated with Markers of Hemolysis and Inflammation in a Large Sickle Cell Disease Cohort within the GenoMed4ALL Project

Data Driven Research through the European RADeep Registry and the Use of Artificial Intelligence Towards Personalized Medicine in Sickle Cell Disease

Durable Clinical Benefits with Exagamglogene Autotemcel for Severe Sickle Cell Disease

Availability and Cost of Basic Drugs for Sickle Cell Disease in 13 African Countries

Safety Profile of Crizanlizumab 5.0 Mg/Kg in Sickle Cell Disease: Pooled Data from Clinical Trials

Puberty Onset and Preservation of Fertility in Male Patients with Sickle Cell Disease Treated with Hydroxyurea: Data from the European Sickle Cell Disease Cohort - Hydroxyurea Extension (ESCORT-HU Extension) Study

Sickle Cell Health Awareness, Perspectives, and Experiences (SHAPE) Survey: Findings on the Burden of Sickle Cell Disease and Impact on the Quality of Life of Patients and Caregivers in Gulf Cooperation Council Countries

Exagamglogene Autotemcel for Severe Sickle Cell Disease

The Cs a and Cs b Red Cell Antigens of the Cost Blood Group Collection Correspond to the HNA-3a and HNA-3b Neutrophil Antigens: Unexpected Twins with Implications for Sickle Cell Anemia

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only